{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:26:29Z","timestamp":1790267189261,"version":"4.1.0"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Septic arthritis (SA) represents a medical emergency that needs immediate diagnosis and urgent treatment. Despite aggressive treatment and rapid diagnosis of the causative agent, the mortality and lifelong disability, associated with septic arthritis remain high as close to 11%. Moreover, with the rise in drug resistance, the rates of failure of conventional antibiotic therapy have also increased. Among the etiological agents frequently isolated from cases of septic arthritis, <jats:italic>Staphylococcus aureus<\/jats:italic> emerges as a dominating pathogen, and to worsen, the rise in methicillin-resistant <jats:italic>S. aureus<\/jats:italic> (MRSA) isolates in bone and joint infections is worrisome. MRSA associated cases of septic arthritis exhibit higher mortality, longer hospital stay, and higher treatment failure with poorer clinical outcomes as compared to cases caused by the sensitive strain i.e methicillin-sensitive <jats:italic>S. aureus<\/jats:italic> (MSSA).<\/jats:p><jats:p>In addition to this, equal or even greater damage is imposed by the exacerbated immune response mounted by the patient\u2019s body in a futile attempt to eradicate the bacteria. The antibiotic therapy may not be sufficient enough to control the progression of damage to the joint involved thus, adding to higher mortality and disability rates despite the prompt and timely start of treatment. This situation implies that efforts and focus towards studying\/understanding new strategies for improved management of sepsis arthritis is prudent and worth exploring.<\/jats:p><jats:p>The review article aims to give a complete insight into the new therapeutic approaches studied by workers lately in this field. To the best of our knowledge studies highlighting the novel therapeutic strategies against septic arthritis are limited in the literature, although articles on pathogenic mechanism and choice of antibiotics for therapy, current treatment algorithms followed have been discussed by workers in the past. The present study presents and discusses the new alternative approaches, their mechanism of action, proof of concept, and work done so far towards their clinical success. This will surely help to enlighten the researchers with comprehensive knowledge of the new interventions that can be used as an adjunct therapy along with conventional treatment protocol for improved success rates.<\/jats:p>","DOI":"10.1186\/s12891-021-04383-6","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T16:04:43Z","timestamp":1623254683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Novel therapeutic interventions towards improved management of septic arthritis"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2497-5035","authenticated-orcid":false,"given":"Jian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liucai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"issue":"4","key":"4383_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1469-0691.2006.01366.x","volume":"12","author":"JW Smith","year":"2006","unstructured":"Smith JW, Chalupa P, Shabaz HM. Infectious arthritis: clinical features, laboratory findings and treatment. Clin Microbiol Infect. 2006;12(4):309\u201314. https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01366.x.","journal-title":"Clin Microbiol Infect."},{"key":"4383_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S0140-6736(09)61595-6","volume":"375","author":"CJ Mathews","year":"2010","unstructured":"Mathews CJ, Weston VC, Jones A, Field M, Coakley G. Bacterial septic arthritis in adults. Lancet. 2010;375:846\u201355.","journal-title":"Lancet."},{"issue":"3","key":"4383_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2217\/ijr.12.11","volume":"7","author":"MM Lynn","year":"2012","unstructured":"Lynn MM, Mathews CJ. Advances in the management of bacterial septic arthritis. Int J Clin Rheumatol. 2012;7(3):335\u201342.","journal-title":"Int J Clin Rheumatol."},{"issue":"3","key":"4383_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S1473-3099(19)30419-0","volume":"20","author":"SGF Abram","year":"2020","unstructured":"Abram SGF, Alvand A, Judge A, Beard DJ, Price AJ. Mortality and adverse joint outcomes following septic arthritis of the native knee: a longitudinal cohort study of patients receiving arthroscopic washout. Lancet Infect Dis. 2020;20(3):341\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(19)30419-0.","journal-title":"Lancet Infect Dis."},{"issue":"1","key":"4383_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","volume":"15","author":"S Kwan Tat","year":"2004","unstructured":"Kwan Tat S, Padrines M, Th\u00e9oleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004;15(1):49\u201360. https:\/\/doi.org\/10.1016\/j.cytogfr.2003.10.005.","journal-title":"Cytokine Growth Factor Rev."},{"key":"4383_CR6","doi-asserted-by":"publisher","first-page":"38043","DOI":"10.1038\/srep38043","volume":"6","author":"A Corrado","year":"2016","unstructured":"Corrado A, Donato P, Maccari S, Cecchi R, Spadafina T, Arcidiacono L, et al. Staphylococcus aureus-dependent septic arthritis in murine knee joints: local immune response and beneficial effects of vaccination. Sci Rep. 2016;6:38043. https:\/\/doi.org\/10.1038\/srep38043.","journal-title":"Sci Rep."},{"issue":"4","key":"4383_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/ard.2006.058909","volume":"66","author":"CJ Mathews","year":"2007","unstructured":"Mathews CJ, Kingsley G, Field M, et al. Management of septic arthritis: a systematic review. Ann Rheum Dis. 2007;66(4):440\u20135. https:\/\/doi.org\/10.1136\/ard.2006.058909.","journal-title":"Ann Rheum Dis."},{"key":"4383_CR8","doi-asserted-by":"publisher","first-page":"602137","DOI":"10.1155\/2015\/602137","volume":"2015","author":"A Miller","year":"2015","unstructured":"Miller A, Abduljabbar F, Jarzem P. Polyarticular Septic Arthritis in an Immunocompetent Adult: A Case Report and Review of the Literature. Case Rep Orthop. 2015;2015:602137. https:\/\/doi.org\/10.1155\/2015\/602137.","journal-title":"Case Rep Orthop."},{"issue":"4","key":"4383_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1128\/cmr.15.4.527-544.2002","volume":"15","author":"ME Shirtliff","year":"2002","unstructured":"Shirtliff ME, Mader JT. Acute septic arthritis. Clin Microbiol Rev. 2002;15(4):527\u201344. https:\/\/doi.org\/10.1128\/cmr.15.4.527-544.2002.","journal-title":"Clin Microbiol Rev."},{"issue":"3","key":"4383_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1136\/ard.61.3.267","volume":"61","author":"JJ Dubost","year":"2002","unstructured":"Dubost JJ, Soubrier M, De Champs C, Ristori JM, Bussi\u00e9re JL, Sauvezie B. No changes in the distribution of organisms responsible for septic arthritis over a 20 year period. Ann Rheum Dis. 2002;61(3):267\u20139. https:\/\/doi.org\/10.1136\/ard.61.3.267.","journal-title":"Ann Rheum Dis."},{"issue":"12","key":"4383_CR11","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/art.1780381215","volume":"38","author":"CJ Kaandorp","year":"1995","unstructured":"Kaandorp CJ, Van Schaardenburg D, Krijnen P, Habbema JD, van de Laar MA. Risk factors for septic arthritis in patients with joint disease. A prospective study. Arthritis Rheum. 1995;38(12):1819\u201325. https:\/\/doi.org\/10.1002\/art.1780381215.","journal-title":"Arthritis Rheum."},{"issue":"11","key":"4383_CR12","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1503\/cmaj.050258","volume":"176","author":"RB Kherani","year":"2007","unstructured":"Kherani RB, Shojania K. Septic arthritis in patients with pre-existing inflammatory arthritis [published correction appears in CMAJ. 2007;177(5):489]. CMAJ. 2007;176(11):1605\u20138. https:\/\/doi.org\/10.1503\/cmaj.050258.","journal-title":"CMAJ."},{"issue":"1","key":"4383_CR13","doi-asserted-by":"publisher","first-page":"e0059","DOI":"10.2106\/JBJS.RVW.19.00059","volume":"8","author":"JG Elsissy","year":"2020","unstructured":"Elsissy JG, Liu JN, Wilton PJ, Nwachuku I, Gowd AK, Amin NH. Bacterial Septic Arthritis of the Adult Native Knee Joint: A Review. JBJS Rev. 2020;8(1):e0059. https:\/\/doi.org\/10.2106\/JBJS.RVW.19.00059.","journal-title":"JBJS Rev."},{"key":"4383_CR14","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1553-2712.2011.01121.x","volume":"18","author":"CR Carpenter","year":"2011","unstructured":"Carpenter CR, Schuur JD, Everett WW, Pines JM. Evidence-based diagnostics: adult septic arthritis. Acad Emerg Med. 2011;18:781.","journal-title":"Acad Emerg Med"},{"issue":"2","key":"4383_CR15","doi-asserted-by":"publisher","first-page":"e01358","DOI":"10.1128\/JCM.01358-17","volume":"56","author":"C Costales","year":"2018","unstructured":"Costales C, Butler-Wu SM. A Real Pain: Diagnostic Quandaries and Septic Arthritis. J Clin Microbiol. 2018;56(2):e01358\u201317. https:\/\/doi.org\/10.1128\/JCM.01358-17.","journal-title":"J Clin Microbiol."},{"issue":"5","key":"4383_CR16","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/art.1780400516","volume":"40","author":"CJ Kaandorp","year":"1997","unstructured":"Kaandorp CJ, Krijnen P, Moens HJ, Habbema JD, van Schaardenburg D. The outcome of bacterial arthritis: a prospective community-based study. Arthritis Rheum. 1997;40(5):884\u201392. https:\/\/doi.org\/10.1002\/art.1780400516.","journal-title":"Arthritis Rheum."},{"issue":"1","key":"4383_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00264-017-3565-4","volume":"42","author":"SW Jung","year":"2018","unstructured":"Jung SW, Kim DH, Shin SJ, Kang BY, Eho YJ, Yang SW. Septic arthritis associated with systemic sepsis. Int Orthop. 2018;42(1):1\u20137. https:\/\/doi.org\/10.1007\/s00264-017-3565-4.","journal-title":"Int Orthop."},{"key":"4383_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1749-799X-3-33","volume":"3","author":"A Al-Ahaideb","year":"2008","unstructured":"Al-Ahaideb A. Septic arthritis in patients with rheumatoid arthritis. J Orthop Surg Res. 2008;3:33. https:\/\/doi.org\/10.1186\/1749-799X-3-33.","journal-title":"J Orthop Surg Res."},{"key":"4383_CR19","doi-asserted-by":"crossref","unstructured":"Minguez S, Molinos S, Mateo L. Septic arthritis due to methicillin-resistant Staphylococcus aureus in adults. Reumatol Clin. 2015;11(November-December (6)):381\u2013386","DOI":"10.1016\/j.reumae.2015.09.002"},{"key":"4383_CR20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00002281-200107000-00012","volume":"12","author":"G Ho","year":"2001","unstructured":"Ho G. Bacterial arthritis. Curr Opin Rheumatol. 2001;12:310\u20134.","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"4383_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/BOR.0b013e3283036975","volume":"20","author":"CJ Mathews","year":"2008","unstructured":"Mathews CJ, Coakley G. Septic arthritis: current diagnostic and therapeutic algorithm. Curr Opin Rheumatol. 2008;20(4):457\u201362. https:\/\/doi.org\/10.1097\/BOR.0b013e3283036975.","journal-title":"Curr Opin Rheumatol."},{"key":"4383_CR22","unstructured":"Lidgren L. Septic arthritis and osteomyelitis. In: Hochberg MC, Silman AJ, Smolen JS, et al., editors. Rheumatology. Toronto: Mosby; 2003:1055-1066."},{"issue":"2","key":"4383_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s1521-6942(02)00106-7","volume":"17","author":"S Nade","year":"2003","unstructured":"Nade S. Septic arthritis. Best Pract Res Clin Rheumatol. 2003;17(2):183\u2013200. https:\/\/doi.org\/10.1016\/s1521-6942(02)00106-7.","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"6","key":"4383_CR24","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/BCO.0b013e318230efcf","volume":"22","author":"P Stoodley","year":"2011","unstructured":"Stoodley P, Ehrlich GD, Sedghizadeh PP, et al. Orthopaedic biofilm infections. Curr Orthop Pract. 2011;22(6):558\u201363. https:\/\/doi.org\/10.1097\/BCO.0b013e318230efcf.","journal-title":"Curr Orthop Pract."},{"issue":"5","key":"4383_CR25","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/jac\/dkr047","volume":"66","author":"O Clerc","year":"2011","unstructured":"Clerc O, Prod'hom G, Greub G, Zanetti G, Senn L. Adult native septic arthritis: a review of 10 years of experience and lessons for empirical antibiotic therapy. J Antimicrob Chemother. 2011;66(5):1168\u201373. https:\/\/doi.org\/10.1093\/jac\/dkr047.","journal-title":"J Antimicrob Chemother."},{"issue":"5","key":"4383_CR26","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s10156-011-0244-z","volume":"17","author":"T Okano","year":"2011","unstructured":"Okano T, Enokida M, Otsuki R, Hagino H, Teshima R. Recent trends in adult-onset septic arthritis of the knee and hip: retrospective analysis of patients treated during the past 50 years. J Infect Chemother. 2011;17(5):666\u201370. https:\/\/doi.org\/10.1007\/s10156-011-0244-z.","journal-title":"J Infect Chemother."},{"issue":"6","key":"4383_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1302\/0301-620X.87B6.16292","volume":"87","author":"PV Giannoudis","year":"2005","unstructured":"Giannoudis PV, Parker J, Wilcox MH. Methicillin-resistant Staphylococcus aureus in trauma and orthopaedic practice. J Bone Joint Surg Br. 2005;87(6):749\u201354. https:\/\/doi.org\/10.1302\/0301-620X.87B6.16292.","journal-title":"J Bone Joint Surg Br."},{"issue":"11","key":"4383_CR28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1302\/0301-620X.90B11.20771","volume":"90","author":"A Patel","year":"2008","unstructured":"Patel A, Calfee RP, Plante M, Fischer SA, Arcand N, Born C. Methicillin-resistant Staphylococcus aureus in orthopaedic surgery. J Bone Joint Surg Br. 2008;90(11):1401\u20136. https:\/\/doi.org\/10.1302\/0301-620X.90B11.20771.","journal-title":"J Bone Joint Surg Br."},{"issue":"1","key":"4383_CR29","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.4314\/ahs.v19i1.12","volume":"19","author":"T Latha","year":"2019","unstructured":"Latha T, Anil B, Manjunatha H, Chiranjay M, Elsa D, Baby N, et al. MRSA: the leading pathogen of orthopedic infection in a tertiary care hospital, South India. Afr Health Sci. 2019;19(1):1393\u2013401. https:\/\/doi.org\/10.4314\/ahs.v19i1.12.","journal-title":"Afr Health Sci."},{"issue":"9","key":"4383_CR30","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/rheumatology\/kei035","volume":"44","author":"JJ Ross","year":"2005","unstructured":"Ross JJ, Davidson L. Methicillin-resistant Staphylococcus aureus septic arthritis: an emerging clinical syndrome. Rheumatology (Oxford). 2005;44(9):1197\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/kei035.","journal-title":"Rheumatology (Oxford)."},{"issue":"7","key":"4383_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00402-007-0285-z","volume":"127","author":"SS Al-Nammari","year":"2007","unstructured":"Al-Nammari SS, Bobak P, Venkatesh R. Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis. Arch Orthop Trauma Surg. 2007;127(7):537\u201342.","journal-title":"Arch Orthop Trauma Surg."},{"issue":"1","key":"4383_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jor.2017.11.007","volume":"15","author":"K Combs","year":"2017","unstructured":"Combs K, Cox K. Clinical outcomes involving patients that develop septic arthritis with methicillin sensitive Staphylococcus aureus versus methicillin resistant Staphylococcus aureus. J Orthop. 2017;15(1):9\u201312.","journal-title":"J Orthop."},{"issue":"8","key":"4383_CR33","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jama.279.8.593","volume":"279","author":"BC Herold","year":"1998","unstructured":"Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279(8):593\u20138. https:\/\/doi.org\/10.1001\/jama.279.8.593.","journal-title":"JAMA."},{"issue":"8","key":"4383_CR34","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/01.inf.0000133044.79130.2a","volume":"23","author":"G Mart\u00ednez-Aguilar","year":"2004","unstructured":"Mart\u00ednez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO Jr, Kaplan SL. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004;23(8):701\u20136. https:\/\/doi.org\/10.1097\/01.inf.0000133044.79130.2a.","journal-title":"Pediatr Infect Dis J."},{"issue":"6","key":"4383_CR35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/01.bpo.0000242431.91489.b4","volume":"26","author":"SR Arnold","year":"2006","unstructured":"Arnold SR, Elias D, Buckingham SC, Thomas ED, Novais E, Arkader A, et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop. 2006;26(6):703\u20138. https:\/\/doi.org\/10.1097\/01.bpo.0000242431.91489.b4.","journal-title":"J Pediatr Orthop."},{"issue":"22","key":"4383_CR36","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","volume":"290","author":"TS Naimi","year":"2003","unstructured":"Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290(22):2976\u201384. https:\/\/doi.org\/10.1001\/jama.290.22.2976 PMID: 14665659.","journal-title":"JAMA."},{"issue":"2","key":"4383_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jhin.2007.06.003","volume":"67","author":"BC Millar","year":"2007","unstructured":"Millar BC, Loughrey A, Elborn JS, Moore JE. Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect. 2007;67(2):109\u201313. https:\/\/doi.org\/10.1016\/j.jhin.2007.06.003.","journal-title":"J Hosp Infect."},{"key":"4383_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/ar2","volume":"1","author":"AM Krieg","year":"1999","unstructured":"Krieg AM. A possible cause of joint destruction in septic arthritis. Arthritis Res Ther. 1999;1:3.","journal-title":"Arthritis Res Ther"},{"key":"4383_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1678-9199-20-19","volume":"20","author":"PM Colavite","year":"2014","unstructured":"Colavite PM, Sartori A. Septic arthritis: immunopathogenesis, experimental models and therapy. J Venom Anim Toxins Incl Trop Dis. 2014;20:19. https:\/\/doi.org\/10.1186\/1678-9199-20-19.","journal-title":"J Venom Anim Toxins Incl Trop Dis."},{"issue":"2","key":"4383_CR40","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/ijms19020468","volume":"19","author":"D Boff","year":"2018","unstructured":"Boff D, Crijns H, Teixeira MM, Amaral FA, Proost P. Neutrophils: Beneficial and Harmful Cells in Septic Arthritis. Int J Mol Sci. 2018;19(2):468. https:\/\/doi.org\/10.3390\/ijms19020468.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"4383_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0889-857x(02)00080-7","volume":"29","author":"I Garcia-De La Torre","year":"2003","unstructured":"Garcia-De La Torre I. Advances in the management of septic arthritis. Rheum Dis Clin North Am. 2003;29(1):61\u201375. https:\/\/doi.org\/10.1016\/s0889-857x(02)00080-7.","journal-title":"Rheum Dis Clin North Am."},{"issue":"2","key":"4383_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5811\/westjem.2018.10.40974","volume":"20","author":"B Long","year":"2019","unstructured":"Long B, Koyfman A, Gottlieb M. Evaluation and Management of Septic Arthritis and its Mimics in the Emergency Department. West J Emerg Med. 2019;20(2):331\u201341. https:\/\/doi.org\/10.5811\/westjem.2018.10.40974.","journal-title":"West J Emerg Med."},{"issue":"29","key":"4383_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.15585\/mmwr.mm6629a3","volume":"66","author":"K Ross","year":"2017","unstructured":"Ross K, Mehr J, Carothers B, Greeley R, Benowitz I, McHugh L, et al. Outbreak of septic arthritis associated with intra-articular injections at an outpatient practice - New Jersey, 2017. MMWR Morb Mortal Wkly Rep. 2017;66(29):777\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm6629a3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"4383_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.berh.2006.08.001","volume":"20","author":"A Tarkowski","year":"2006","unstructured":"Tarkowski A. Infection and musculoskeletal conditions: Infectious arthritis. Best Pract Res Clin Rheumatol. 2006;20(6):1029\u201344. https:\/\/doi.org\/10.1016\/j.berh.2006.08.001.","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"4383_CR45","first-page":"277","volume":"16","author":"L Haywood","year":"2001","unstructured":"Haywood L, Walsh DA. Vasculature of the normal and arthritic synovial joint. Histol Histopathol. 2001;16:277\u201384.","journal-title":"Histol Histopathol."},{"issue":"9097","key":"4383_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0140-6736(97)09522-6","volume":"351","author":"DL Goldenberg","year":"1998","unstructured":"Goldenberg DL. Septic arthritis. Lancet. 1998;351(9097):197\u2013202. https:\/\/doi.org\/10.1016\/S0140-6736(97)09522-6.","journal-title":"Lancet."},{"key":"4383_CR47","first-page":"279","volume":"3","author":"S Hasan","year":"2001","unstructured":"Hasan S, Smith JW. Septic arthritis. Curr Treat Options Infect Dis. 2001;3:279\u201386.","journal-title":"Curr Treat Options Infect Dis"},{"issue":"4","key":"4383_CR48","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.ajpath.2012.07.005","volume":"181","author":"SA Horst","year":"2012","unstructured":"Horst SA, Hoerr V, Beineke A, Kreis C, Tuchscherr L, Kalinka J, et al. A novel mouse model of Staphylococcus aureus chronic osteomyelitis that closely mimics the human infection: an integrated view of disease pathogenesis. Am J Pathol. 2012;181(4):1206\u201314. https:\/\/doi.org\/10.1016\/j.ajpath.2012.07.005.","journal-title":"Am J Pathol."},{"key":"4383_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrmicro3161","volume":"12","author":"TJ Foster","year":"2014","unstructured":"Foster TJ, Geoghegan JA, Ganesh VK, Hook M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol. 2014;12:49\u201362. https:\/\/doi.org\/10.1038\/nrmicro3161.","journal-title":"Nat Rev Microbiol."},{"key":"4383_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-319-11038-7_2","volume":"830","author":"CR Arciola","year":"2015","unstructured":"Arciola CR, Campoccia D, Ehrlich GD, Montanaro L. Biofilm-based implant infections in orthopaedics. Adv Exp Med Biol. 2015;830:29\u201346.","journal-title":"Adv Exp Med Biol"},{"key":"4383_CR51","doi-asserted-by":"publisher","unstructured":"Kim M, Zhao A, Wang A et al. 2017.Surface-attached molecules control Staphylococcus aureus quorum sensing and biofilm development. Nat Microbiol 2, 17080. https:\/\/doi.org\/https:\/\/doi.org\/10.1038\/nmicrobiol.2017.80","DOI":"10.1038\/nmicrobiol.2017.80"},{"key":"4383_CR52","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1574-6968.2006.00281.x","volume":"259","author":"R Biswas","year":"2006","unstructured":"Biswas R, Voggu L, Simon UK, Hentschel P, Thumm G, Gotz F. Activity of the major staphylococcal autolysin Atl. FEMS Microbiol Lett. 2006;259:260\u20138.","journal-title":"FEMS Microbiol Lett"},{"key":"4383_CR53","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1016\/j.biomaterials.2009.08.032","volume":"30","author":"D Campoccia","year":"2009","unstructured":"Campoccia D, Speziale P, Ravaioli S, et al. The presence of both bone sialoprotein-binding protein gene and collagen adhesin gene as a typical virulence trait of the major epidemic cluster in isolates from orthopedic implant infections. Biomaterials. 2009;30:6621\u20138. https:\/\/doi.org\/10.1016\/j.biomaterials.2009.08.032.","journal-title":"Biomaterials."},{"key":"4383_CR54","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1128\/iai.61.10.4119-4125.1993","volume":"61","author":"LM Switalski","year":"1993","unstructured":"Switalski LM, Butcher WG, Caufield PC, Lantz MS. Collagen mediates adhesion of Streptococcus mutans to human dentin. Infect Immun. 1993;61:4119\u201325.","journal-title":"Infect Immun."},{"key":"4383_CR55","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1086\/516520","volume":"176","author":"U Ryding","year":"1997","unstructured":"Ryding U, Flock JI, Flock M, Soderquist B, Christensson B. Expression of collagen-binding protein and types 5 and 8 capsular polysaccharide in clinical isolates of Staphylococcus aureus. J Infect Dis. 1997;176:1096\u20139.","journal-title":"J Infect Dis."},{"key":"4383_CR56","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1128\/IAI.67.3.1045-1049.1999","volume":"67","author":"IM Nilsson","year":"1999","unstructured":"Nilsson IM, Hartford O, Foster T, Tarkowski A. Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect. Immun. 1999;67:1045\u20139.","journal-title":"Infect. Immun."},{"issue":"10","key":"4383_CR57","doi-asserted-by":"publisher","first-page":"e00237","DOI":"10.1128\/IAI.00237-18","volume":"86","author":"K Perez","year":"2018","unstructured":"Perez K, Patel R. Survival of Staphylococcus epidermidis in Fibroblasts and Osteoblasts. Infect Immun. 2018;86(10):e00237\u201318. https:\/\/doi.org\/10.1128\/IAI.00237-18.","journal-title":"Infect Immun."},{"issue":"4","key":"4383_CR58","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/infdis\/jiu514","volume":"211","author":"S Dastgheyb","year":"2015","unstructured":"Dastgheyb S, Parvizi J, Shapiro IM, Hickok NJ, Otto M. Effect of biofilms on recalcitrance of staphylococcal joint infection to antibiotic treatment. J Infect Dis. 2015;211(4):641\u201350. https:\/\/doi.org\/10.1093\/infdis\/jiu514.","journal-title":"J Infect Dis."},{"issue":"6","key":"4383_CR59","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/jor.24584","volume":"38","author":"JM Gilbertie","year":"2020","unstructured":"Gilbertie JM, Schaer TP, Schubert AG, Jacob ME, Menegatti S, Ashton Lavoie R, et al. Platelet-rich plasma lysate displays anti-biofilm properties and restores antimicrobial activity against synovial fluid biofilms in vitro. J Orthop Res. 2020;38(6):1365\u201374. https:\/\/doi.org\/10.1002\/jor.24584.","journal-title":"J Orthop Res."},{"issue":"4","key":"4383_CR60","doi-asserted-by":"publisher","first-page":"e0231791","DOI":"10.1371\/journal.pone.0231791","volume":"15","author":"MJ Pestrak","year":"2020","unstructured":"Pestrak MJ, Gupta TT, Dusane DH, et al. Investigation of synovial fluid induced Staphylococcus aureus aggregate development and its impact on surface attachment and biofilm formation [published correction appears in PLoS One. 2020 May 14;15(5):e0233534]. PLoS One. 2020;15(4):e0231791. https:\/\/doi.org\/10.1371\/journal.pone.0231791.","journal-title":"PLoS One"},{"issue":"8","key":"4383_CR61","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1086\/507633","volume":"43","author":"P Sendi","year":"2006","unstructured":"Sendi P, Rohrbach M, Graber P, Frei R, Ochsner PE, Zimmerli W. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis. 2006;43(8):961\u20137.","journal-title":"Clin Infect Dis."},{"issue":"8","key":"4383_CR62","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2217\/fmb.14.64","volume":"9","author":"SJ McConoughey","year":"2014","unstructured":"McConoughey SJ, Howlin R, Granger JF, et al. Biofilms in periprosthetic orthopedic infections [published correction appears in Future Microbiol. 2014; 9(10):1234]. Future Microbiol. 2014;9(8):987\u20131007.","journal-title":"Future Microbiol."},{"key":"4383_CR63","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fcimb.2014.00099","volume":"4","author":"RA Proctor","year":"2014","unstructured":"Proctor RA, Kriegeskorte A, Kahl BC, Becker K, L\u00f6ffler B, Peters G. Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections. Front Cell Infect Microbiol. 2014;4:99. https:\/\/doi.org\/10.3389\/fcimb.2014.00099.","journal-title":"Front Cell Infect Microbiol."},{"key":"4383_CR64","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1128\/CMR.00069-15","volume":"29","author":"BC Kahl","year":"2016","unstructured":"Kahl BC, Becker K, Loffler B. Clinical significance and pathogenesis of staphylococcal small colony variants in persistent infections. Clin. Microbiol. Rev. 2016;29:401\u201327. https:\/\/doi.org\/10.1128\/CMR.00069-15.","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"4383_CR65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1302\/2058-5241.1.000037","volume":"1","author":"TF Moriarty","year":"2016","unstructured":"Moriarty TF, Kuehl R, Coenye T, et al. Orthopaedic device-related infection: current and future interventions for improved prevention and treatment. EFORT Open Rev. 2016;1(4):89\u201399. https:\/\/doi.org\/10.1302\/2058-5241.1.000037.","journal-title":"EFORT Open Rev."},{"key":"4383_CR66","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3389\/fmicb.2019.01602","volume":"10","author":"J Josse","year":"2019","unstructured":"Josse J, Valour F, Maali Y, et al. Interaction Between Staphylococcal Biofilm and Bone: How Does the Presence of Biofilm Promote Prosthesis Loosening? Front Microbiol. 2019;10:1602. https:\/\/doi.org\/10.3389\/fmicb.2019.01602.","journal-title":"Front Microbiol."},{"issue":"5","key":"4383_CR67","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/eji.1830240523","volume":"24","author":"A Abdelnour","year":"1994","unstructured":"Abdelnour A, Bremell T, Holmdahl R, Tarkowski A. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci. Eur J Immunol. 1994;24(5):1161\u20136. https:\/\/doi.org\/10.1002\/eji.1830240523.","journal-title":"Eur J Immunol."},{"key":"4383_CR68","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/1471-2334-13-400","volume":"13","author":"PM Colavite-Machado","year":"2013","unstructured":"Colavite-Machado PM, Ishikawa LL, Fran\u00e7a TG, Zorzella-Pezavento SF, da Rosa LC, Chiuso-Minicucci F, et al. Differential arthritogenicity of Staphylococcus aureus strains isolated from biological samples. BMC Infect Dis. 2013;13:400. https:\/\/doi.org\/10.1186\/1471-2334-13-400.","journal-title":"BMC Infect Dis."},{"issue":"7","key":"4383_CR69","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1302\/2046-3758.77.BJR-2017-0165.R1","volume":"7","author":"IDM Smith","year":"2018","unstructured":"Smith IDM, Milto KM, Doherty CJ, Amyes SGB, Simpson AHRW, Hall AC. A potential key role for alpha-haemolysin of Staphylococcus aureus in mediating chondrocyte death in septic arthritis. Bone Joint Res. 2018;7(7):457\u201367. https:\/\/doi.org\/10.1302\/2046-3758.77.BJR-2017-0165.R1.","journal-title":"Bone Joint Res."},{"issue":"11","key":"4383_CR70","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/INF.0b013e318133a85e","volume":"26","author":"B Dohin","year":"2007","unstructured":"Dohin B, Gillet Y, Kohler R, Lina G, Vandenesch F, Vanhems P, et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J. 2007;26(11):1042\u20138. https:\/\/doi.org\/10.1097\/INF.0b013e318133a85e.","journal-title":"Pediatr Infect Dis J."},{"issue":"9","key":"4383_CR71","doi-asserted-by":"publisher","first-page":"e7204","DOI":"10.1371\/journal.pone.0007204","volume":"4","author":"AC Cr\u00e9mieux","year":"2009","unstructured":"Cr\u00e9mieux AC, Dumitrescu O, Lina G, Vallee C, C\u00f4t\u00e9 JF, Muffat-Joly M, et al. Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One. 2009;4(9):e7204. https:\/\/doi.org\/10.1371\/journal.pone.0007204.","journal-title":"PLoS One."},{"issue":"1","key":"4383_CR72","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/MOP.0b013e32835c2b42","volume":"25","author":"ER Dodwell","year":"2013","unstructured":"Dodwell ER. Osteomyelitis and septic arthritis in children: current concepts. Curr Opin Pediatr. 2013;25(1):58\u201363.","journal-title":"Curr Opin Pediatr."},{"issue":"4","key":"4383_CR73","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1128\/cmr.16.4.637-646.2003","volume":"16","author":"S Janssens","year":"2003","unstructured":"Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev. 2003;16(4):637\u201346. https:\/\/doi.org\/10.1128\/cmr.16.4.637-646.2003.","journal-title":"Clin Microbiol Rev."},{"issue":"2","key":"4383_CR74","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/jor.21239","volume":"29","author":"I Papathanasiou","year":"2011","unstructured":"Papathanasiou I, Malizos KN, Poultsides L. The catabolic role of toll-like receptor 2 (TLR-2) mediated by the NF-kB pathway in septic arthritis. J Orthop Res. 2011;29(2):247\u201351.","journal-title":"J Orthop Res."},{"key":"4383_CR75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fimmu.2012.00079","volume":"3","author":"L Oliveira-Nascimento","year":"2012","unstructured":"Oliveira-Nascimento L, Massari P, Wetzler LM. The role of TLR2 in infection and immunity. Front Immun. 2012;3:79. https:\/\/doi.org\/10.3389\/fimmu.2012.00079.","journal-title":"Front Immun."},{"key":"4383_CR76","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1128\/iai.63.10.4185-4187.1995","volume":"63","author":"T Bremell","year":"1995","unstructured":"Bremell T, Tarkowski A. Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infect. Immun. 1995;63:4185\u20137.","journal-title":"Infect. Immun."},{"key":"4383_CR77","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1574-6968.2002.tb11466.x","volume":"217","author":"A Tarkowski","year":"2002","unstructured":"Tarkowski A, Bokarewa M, Collins LV, Gjertsson I, Hultgren OH, Jin T, et al. Current status of pathogenetic mechanisms in staphylococcal arthritis. FEMS Microbiol Letters. 2002;217:125\u201332.","journal-title":"FEMS Microbiol Letters"},{"issue":"6","key":"4383_CR78","doi-asserted-by":"publisher","first-page":"R176","DOI":"10.1186\/ar2086","volume":"8","author":"S Kanangat","year":"2006","unstructured":"Kanangat S, Postlethwaite A, Hasty K, et al. Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther. 2006;8(6):R176. https:\/\/doi.org\/10.1186\/ar2086.","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"4383_CR79","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.idc.2017.07.013","volume":"31","author":"R Nair","year":"2017","unstructured":"Nair R, Schweizer ML, Singh N. Septic Arthritis and Prosthetic Joint Infections in Older Adults. Infect Dis Clin North Am. 2017;31(4):715\u201329. https:\/\/doi.org\/10.1016\/j.idc.2017.07.013.","journal-title":"Infect Dis Clin North Am."},{"key":"4383_CR80","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0033-8389(22)00829-6","volume":"26","author":"M Mitchell","year":"1988","unstructured":"Mitchell M, Howard B, Haller J, Sartoris DJ, Resnick D. Septic arthritis. Radiol. Clin. North Am. 1988;26:1295\u2013313.","journal-title":"Radiol. Clin. North Am."},{"issue":"21","key":"4383_CR81","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2174\/138161209788682325","volume":"15","author":"G Diamond","year":"2009","unstructured":"Diamond G, Beckloff N, Weinberg A, Kisich KO. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des. 2009;15(21):2377\u201392. https:\/\/doi.org\/10.2174\/138161209788682325\\.","journal-title":"Curr Pharm Des."},{"issue":"2","key":"4383_CR82","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/07388551.2011.594423","volume":"32","author":"M Pasupuleti","year":"2012","unstructured":"Pasupuleti M, Schmidtchen A, Malmsten M. Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol. 2012;32(2):143\u201371. https:\/\/doi.org\/10.3109\/07388551.2011.594423.","journal-title":"Crit Rev Biotechnol."},{"key":"4383_CR83","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fchem.2017.00063","volume":"5","author":"M Riool","year":"2017","unstructured":"Riool M, de Breij A, Drijfhout JW, Nibbering PH, Zaat SAJ. Antimicrobial Peptides in Biomedical Device Manufacturing. Front Chem. 2017;5:63.","journal-title":"Front Chem."},{"issue":"6","key":"4383_CR84","doi-asserted-by":"publisher","first-page":"488","DOI":"10.24272\/j.issn.2095-8137.2019.062","volume":"40","author":"J Mwangi","year":"2019","unstructured":"Mwangi J, Hao X, Lai R, Zhang ZY. Antimicrobial peptides: new hope in the war against multidrug resistance. Zool Res. 2019;40(6):488\u2013505. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2019.062.","journal-title":"Zool Res"},{"issue":"12","key":"4383_CR85","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/ph6121543","volume":"6","author":"AA Bahar","year":"2013","unstructured":"Bahar AA, Ren D. Antimicrobial peptides. Pharmaceuticals (Basel). 2013;6(12):1543\u201375. https:\/\/doi.org\/10.3390\/ph6121543.","journal-title":"Pharmaceuticals (Basel)."},{"issue":"6","key":"4383_CR86","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1089\/mdr.2017.0392","volume":"24","author":"H Moravej","year":"2018","unstructured":"Moravej H, Moravej Z, Yazdanparast M, Heiat M, Mirhosseini A, Moosazadeh Moghaddam M, et al. Antimicrobial peptides: features, action, and their resistance mechanisms in bacteria. Microb Drug Resist. 2018;24(6):747\u201367. https:\/\/doi.org\/10.1089\/mdr.2017.0392.","journal-title":"Microb Drug Resist."},{"issue":"7","key":"4383_CR87","first-page":"3919","volume":"11","author":"J Lei","year":"2019","unstructured":"Lei J, Sun L, Huang S, et al. The antimicrobial peptides and their potential clinical applications. Am J Transl Res. 2019;11(7):3919\u201331.","journal-title":"Am J Transl Res."},{"key":"4383_CR88","doi-asserted-by":"publisher","unstructured":"Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. 2011;29:464\u201372. https:\/\/doi.org\/10.1016\/j.tibtech.2011.05.001.","DOI":"10.1016\/j.tibtech.2011.05.001"},{"key":"4383_CR89","doi-asserted-by":"publisher","unstructured":"Guilhelmelli F, Vilela N, Albuquerque P, Derengowski Lda S, Silva-Pereira I, Kyaw CM. Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front Microbiol. 2013;4:353. https:\/\/doi.org\/10.3389\/fmicb.2013.00353.","DOI":"10.3389\/fmicb.2013.00353"},{"issue":"4","key":"4383_CR90","doi-asserted-by":"publisher","first-page":"e02340","DOI":"10.1128\/AAC.02340-16","volume":"61","author":"CF Le","year":"2017","unstructured":"Le CF, Fang CM, Sekaran SD. Intracellular Targeting Mechanisms by Antimicrobial Peptides. Antimicrob Agents Chemother. 2017;61(4):e02340\u201316. https:\/\/doi.org\/10.1128\/AAC.02340-16.","journal-title":"Antimicrob Agents Chemother."},{"key":"4383_CR91","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"RE Hancock","year":"2006","unstructured":"Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006;24:1551\u20137. https:\/\/doi.org\/10.1038\/nbt1267.","journal-title":"Nat. Biotechnol."},{"key":"4383_CR92","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fcimb.2016.00194","volume":"6","author":"M Mahlapuu","year":"2016","unstructured":"Mahlapuu M, Hakansson J, Ringstad L, Bj\u00f6rn C. Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol. 2016;6:194.","journal-title":"Front Cell Infect Microbiol."},{"issue":"6","key":"4383_CR93","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/md17060350","volume":"17","author":"HK Kang","year":"2019","unstructured":"Kang HK, Lee HH, Seo CH, Park Y. Antimicrobial and immunomodulatory properties and applications of marine-derived proteins and peptides. Mar Drugs. 2019;17(6):350. https:\/\/doi.org\/10.3390\/md17060350.","journal-title":"Mar Drugs."},{"issue":"5439","key":"4383_CR94","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.286.5439.525","volume":"286","author":"D Yang","year":"1999","unstructured":"Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999;286(5439):525\u20138. https:\/\/doi.org\/10.1126\/science.286.5439.525.","journal-title":"Science."},{"issue":"12","key":"4383_CR95","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.4049\/jimmunol.171.12.6690","volume":"171","author":"GS Tjabringa","year":"2003","unstructured":"Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, S\u00f8rensen OE, Borregaard N, et al. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol. 2003;171(12):6690\u20136. https:\/\/doi.org\/10.4049\/jimmunol.171.12.6690.","journal-title":"J Immunol."},{"issue":"2","key":"4383_CR96","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5114\/ceji.2015.51359","volume":"40","author":"J Agier","year":"2015","unstructured":"Agier J, Efenberger M, Brzezi\u0144ska-B\u0142aszczyk E. Cathelicidin impact on inflammatory cells. Cent Eur J Immunol. 2015;40(2):225\u201335. https:\/\/doi.org\/10.5114\/ceji.2015.51359.","journal-title":"Cent Eur J Immunol."},{"issue":"4","key":"4383_CR97","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.4049\/jimmunol.176.4.2455","volume":"176","author":"N Mookherjee","year":"2006","unstructured":"Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, Hokamp K, et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol. 2006;176(4):2455\u201364. https:\/\/doi.org\/10.4049\/jimmunol.176.4.2455.","journal-title":"J Immunol."},{"issue":"9","key":"4383_CR98","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1084\/jem.20090480","volume":"206","author":"D Ganguly","year":"2009","unstructured":"Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med. 2009;206(9):1983\u201394. https:\/\/doi.org\/10.1084\/jem.20090480.","journal-title":"J Exp Med."},{"key":"4383_CR99","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3389\/fimmu.2020.02077","volume":"11","author":"W Liang","year":"2020","unstructured":"Liang W, Diana J. The Dual Role of Antimicrobial Peptides in Autoimmunity. Front Immunol. 2020;11:2077. https:\/\/doi.org\/10.3389\/fimmu.2020.02077.","journal-title":"Front Immunol."},{"key":"4383_CR100","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1203\/00006450-199608000-00011","volume":"40","author":"I Mattsby-Baltzer","year":"1996","unstructured":"Mattsby-Baltzer I, Roseanu A, Motas C, Elverfors J, Engberg I, Hanson LA. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res. 1996;40:257\u201362. https:\/\/doi.org\/10.1203\/00006450-199608000-00011.","journal-title":"Pediatr. Res."},{"issue":"5","key":"4383_CR101","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1128\/AAC.49.5.1727-1732.2005","volume":"49","author":"DM Bowdish","year":"2005","unstructured":"Bowdish DM, Davidson DJ, Scott MG, Hancock RE. Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother. 2005;49(5):1727\u201332. https:\/\/doi.org\/10.1128\/AAC.49.5.1727-1732.2005.","journal-title":"Antimicrob Agents Chemother."},{"issue":"10","key":"4383_CR102","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.4049\/jimmunol.1700985","volume":"199","author":"BC Wu","year":"2017","unstructured":"Wu BC, Lee AH, Hancock REW. Mechanisms of the innate defense regulator peptide-1002 anti-inflammatory activity in a sterile inflammation mouse model. J Immunol. 2017;199(10):3592\u2013603. https:\/\/doi.org\/10.4049\/jimmunol.1700985.","journal-title":"J Immunol."},{"key":"4383_CR103","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fvets.2019.00233","volume":"6","author":"B Levast","year":"2019","unstructured":"Levast B, Hogan D, van Kessel J, et al. synthetic cationic peptide idr-1002 and human cathelicidin ll37 modulate the cell innate response but differentially impact PRRSV replication in vitro. Front Vet Sci. 2019;6:233. https:\/\/doi.org\/10.3389\/fvets.2019.00233.","journal-title":"Front Vet Sci."},{"issue":"3","key":"4383_CR104","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.it.2008.12.003","volume":"30","author":"Y Lai","year":"2009","unstructured":"Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009;30(3):131\u201341. https:\/\/doi.org\/10.1016\/j.it.2008.12.003.","journal-title":"Trends Immunol."},{"issue":"6","key":"4383_CR105","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/ijms20061417","volume":"20","author":"C Shao","year":"2019","unstructured":"Shao C, Li W, Tan P, Shan A, Dou X, Ma D, et al. Symmetrical modification of minimized dermaseptins to extend the spectrum of antimicrobials with endotoxin neutralization potency. Int J Mol Sci. 2019;20(6):1417. https:\/\/doi.org\/10.3390\/ijms20061417.","journal-title":"Int J Mol Sci."},{"issue":"9","key":"4383_CR106","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1128\/AAC.03163-14","volume":"58","author":"F Reffuveille","year":"2014","unstructured":"Reffuveille F, de la Fuente-N\u00fa\u00f1ez C, Mansour S, Hancock RE. A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob Agents Chemother. 2014;58(9):5363\u201371.","journal-title":"Antimicrob Agents Chemother."},{"key":"4383_CR107","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s12602-018-9465-0","volume":"11","author":"A Lewies","year":"2018","unstructured":"Lewies A, Du Plessis LH, Wentzel JF. Antimicrobial peptides: the achilles' heel of antibiotic resistance? Probiot. Antimicrob. Proteins. 2018;11:370\u201381. https:\/\/doi.org\/10.1007\/s12602-018-9465-0.","journal-title":"Probiot. Antimicrob. Proteins."},{"issue":"6","key":"4383_CR108","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00428-009-0780-4","volume":"454","author":"D Varoga","year":"2009","unstructured":"Varoga D, Klostermeier E, Paulsen F, Wruck C, Lippross S, Brandenburg LO, et al. The antimicrobial peptide HBD-2 and the Toll-like receptors-2 and -4 are induced in synovial membranes in case of septic arthritis. Virchows Arch. 2009;454(6):685\u201394. https:\/\/doi.org\/10.1007\/s00428-009-0780-4.","journal-title":"Virchows Arch."},{"key":"4383_CR109","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/path.1224","volume":"198","author":"F Paulsen","year":"2002","unstructured":"Paulsen F, Pufe T, Conradi L, et al. Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. J Pathol. 2002;198:369\u201377.","journal-title":"J Pathol."},{"key":"4383_CR110","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1128\/CDLI.8.5.1021-1023.2001","volume":"8","author":"F Paulsen","year":"2001","unstructured":"Paulsen F, Pufe T, Petersen W, Tillmann B. Expression of natural peptide antibiotics in human articular cartilage and synovial membrane. Clin Diagn Lab Immunol. 2001;8:1021\u20133.","journal-title":"Clin Diagn Lab Immunol."},{"issue":"10","key":"4383_CR111","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.joca.2019.06.007","volume":"27","author":"D Elezagic","year":"2019","unstructured":"Elezagic D, M\u00f6rgelin M, Hermes G, Hamprecht A, Sengle G, Lau D, et al. Antimicrobial peptides derived from the cartilage.-specific C-type lectin domain family 3 member A (CLEC3A) - potential in the prevention and treatment of septic arthritis. Osteoarthritis Cartilage. 2019;27(10):1564\u201373. https:\/\/doi.org\/10.1016\/j.joca.2019.06.007.","journal-title":"Osteoarthritis Cartilage."},{"key":"4383_CR112","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3389\/fmicb.2018.00667","volume":"9","author":"PVM Reis","year":"2018","unstructured":"Reis PVM, Boff D, Verly RM, Melo-Braga MN, Cort\u00e9s ME, Santos DM, et al. LyeTxI-b, a synthetic peptide derived from lycosa erythrognatha spider venom, shows potent antibiotic activity in Vitro and in Vivo. Front Microbiol. 2018;9:667. https:\/\/doi.org\/10.3389\/fmicb.2018.00667.","journal-title":"Front Microbiol."},{"issue":"8","key":"4383_CR113","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1021\/acsami.5b03697","volume":"8","author":"H Yazici","year":"2016","unstructured":"Yazici H, O'Neill MB, Kacar T, et al. Engineered Chimeric Peptides as Antimicrobial Surface Coating Agents toward Infection-Free Implants. ACS Appl Mater Interfaces. 2016;8(8):5070\u201381.","journal-title":"ACS Appl Mater Interfaces."},{"key":"4383_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2015.12.003","volume":"222","author":"A de Breij","year":"2016","unstructured":"de Breij A, Riool M, Kwakman PH, et al. Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145. J Control Release. 2016;222:1\u20138.","journal-title":"J Control Release."},{"issue":"1","key":"4383_CR115","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41598-017-01698-0","volume":"7","author":"N Bormann","year":"2017","unstructured":"Bormann N, Koliszak A, Kasper S, Schoen L, Hilpert K, Volkmer R, et al. A short artificial antimicrobial peptide shows potential to prevent or treat bone infections. Sci Rep. 2017;7(1):1506. https:\/\/doi.org\/10.1038\/s41598-017-01698-0.","journal-title":"Sci Rep."},{"key":"4383_CR116","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.2147\/DDDT.S147450","volume":"11","author":"A Almaaytah","year":"2017","unstructured":"Almaaytah A, Mohammed GK, Abualhaijaa A, Al-Balas Q. Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria. Drug Des Devel Ther. 2017;11:3159\u201370. https:\/\/doi.org\/10.2147\/DDDT.S147450.","journal-title":"Drug Des Devel Ther."},{"key":"4383_CR117","doi-asserted-by":"crossref","unstructured":"Kang J, Dietz MJ, Li B. 2019.Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms. PLoS One. 14(6):e0216676.","DOI":"10.1371\/journal.pone.0216676"},{"issue":"1","key":"4383_CR118","doi-asserted-by":"publisher","first-page":"109","DOI":"10.7150\/thno.38388","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Shi X, Zhu Y, et al. On-demand storage and release of antimicrobial peptides using Pandora's box-like nanotubes gated with a bacterial infection-responsive polymer. Theranostics. 2020;10(1):109\u201322.","journal-title":"Theranostics"},{"issue":"2","key":"4383_CR119","doi-asserted-by":"publisher","first-page":"e03258","DOI":"10.1128\/mBio.03258-19","volume":"11","author":"HR Lee","year":"2020","unstructured":"Lee HR, You DG, Kim HK, Sohn JW, Kim MJ, Park JK, et al. Romo1-derived antimicrobial peptide is a new antimicrobial agent against multidrug-resistant bacteria in a murine model of sepsis. mBio. 2020;11(2):e03258\u201319. https:\/\/doi.org\/10.1128\/mBio.03258-19.","journal-title":"mBio"},{"key":"4383_CR120","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2165\/00063030-200216010-00006","volume":"16","author":"D Duckworth","year":"2002","unstructured":"Duckworth D, Gulig P. Bacteriophage: potential treatment for bacterial infections. Biodrugs. 2002;16:57\u201362.","journal-title":"Biodrugs."},{"key":"4383_CR121","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/138920108785161604","volume":"9","author":"J Azeredo","year":"2008","unstructured":"Azeredo J, Sutherland IW. The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol. 2008;9:261\u20136.","journal-title":"Curr Pharm Biotechnol."},{"issue":"3","key":"4383_CR122","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","volume":"45","author":"A Sulakvelidze","year":"2001","unstructured":"Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy. Antimicrob Agents Chemother. 2001;45(3):649\u201359. https:\/\/doi.org\/10.1128\/AAC.45.3.649-659.2001.","journal-title":"Antimicrob Agents Chemother."},{"key":"4383_CR123","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tibtech.2010.08.001","volume":"28","author":"M Kutateladze","year":"2010","unstructured":"Kutateladze M, Adamia R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 2010;28:591\u20135.","journal-title":"Trends Biotechnol."},{"key":"4383_CR124","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11274-009-9991-8","volume":"25","author":"MS Bedi","year":"2009","unstructured":"Bedi MS, Verma V, Chhibber S. Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055. World J Microbiol Biotechnol. 2009;25:1145\u201351.","journal-title":"World J Microbiol Biotechnol."},{"issue":"2","key":"4383_CR125","doi-asserted-by":"publisher","first-page":"e56022","DOI":"10.1371\/journal.pone.0056022","volume":"8","author":"S Chhibber","year":"2013","unstructured":"Chhibber S, Kaur T, Kaur S. Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections. PLoS One. 2013;8(2):e56022. https:\/\/doi.org\/10.1371\/journal.pone.0056022.","journal-title":"PLoS One."},{"issue":"6","key":"4383_CR126","doi-asserted-by":"publisher","first-page":"e0157626","DOI":"10.1371\/journal.pone.0157626","volume":"11","author":"S Kaur","year":"2016","unstructured":"Kaur S, Harjai K, Chhibber S. In vivo assessment of phage and linezolid based implant coatings for treatment of methicillin resistant S. aureus (MRSA) mediated orthopaedic device related infections. PLoS One. 2016;11(6):e0157626.","journal-title":"PLoS One"},{"key":"4383_CR127","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-81-322-1777-0_7","volume":"807","author":"R Bragg","year":"2014","unstructured":"Bragg R, van der Westhuizen W, Lee JY, Coetsee E, Boucher C. Bacteriophages as potential treatment option for antibiotic resistant bacteria. Adv Exp Med Biol. 2014;807:97\u2013110. https:\/\/doi.org\/10.1007\/978-81-322-1777-0_7.","journal-title":"Adv Exp Med Biol."},{"issue":"9","key":"4383_CR128","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","volume":"42","author":"T Luong","year":"2020","unstructured":"Luong T, Salabarria AC, Roach DR. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going? Clin Ther. 2020;42(9):1659\u201380. https:\/\/doi.org\/10.1016\/j.clinthera.2020.07.014.","journal-title":"Clin Ther."},{"key":"4383_CR129","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2147\/DDDT.S251171","volume":"14","author":"MM Taati","year":"2020","unstructured":"Taati MM, Khoshbayan A, Chegini Z, Farahani I, Shariati A. Bacteriophages, a new therapeutic solution for inhibiting multidrug-resistant bacteria causing wound infection: lesson from animal models and clinical trials. Drug Des Devel Ther. 2020;14:1867\u201383.","journal-title":"Drug Des Devel Ther."},{"key":"4383_CR130","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fcimb.2017.00418","volume":"7","author":"SA Fong","year":"2017","unstructured":"Fong SA, Drilling A, Morales S, et al. Activity of Bacteriophages in Removing Biofilms of Pseudomonas aeruginosa Isolates from Chronic Rhinosinusitis Patients. Front Cell Infect Microbiol. 2017;7:418. https:\/\/doi.org\/10.3389\/fcimb.2017.00418.","journal-title":"Front Cell Infect Microbiol."},{"key":"4383_CR131","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/antibiotics9050268","volume":"9","author":"C Ferriol-Gonz\u00e1lez","year":"2020","unstructured":"Ferriol-Gonz\u00e1lez C, Domingo-Calap P. Phages for Biofilm Removal. Antibiotics. 2020;9:268.","journal-title":"Antibiotics"},{"issue":"14","key":"4383_CR132","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2174\/0929867322666150209152851","volume":"22","author":"Z Drulis-Kawa","year":"2015","unstructured":"Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B. Bacteriophages and phage-derived proteins--application approaches. Curr Med Chem. 2015;22(14):1757\u201373. https:\/\/doi.org\/10.2174\/0929867322666150209152851.","journal-title":"Curr Med Chem."},{"key":"4383_CR133","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/ph8030559","volume":"8","author":"ST Abedon","year":"2015","unstructured":"Abedon ST. Ecology of anti-biofilm agents II: bacteriophage exploitation and biocontrol of biofilm bacteria. Pharmaceuticals. 2015;8:559\u201389.","journal-title":"Pharmaceuticals."},{"issue":"6","key":"4383_CR134","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s00253-018-8811-1","volume":"102","author":"B Maciejewska","year":"2018","unstructured":"Maciejewska B, Olszak T, Drulis-Kawa Z. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application? Appl Microbiol Biotechnol. 2018;102(6):2563\u201381.","journal-title":"Appl Microbiol Biotechnol."},{"key":"4383_CR135","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fcimb.2019.00363","volume":"9","author":"G Loss","year":"2019","unstructured":"Loss G, Sim\u00f5es PM, Valour F, et al. Staphylococcus aureus Small Colony Variants (SCVs): News from a Chronic Prosthetic Joint Infection. Front Cell Infect Microbiol. 2019;9:363. https:\/\/doi.org\/10.3389\/fcimb.2019.00363.","journal-title":"Front Cell Infect Microbiol."},{"key":"4383_CR136","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1128\/IAI.67.5.2677-2681.1999","volume":"67","author":"M Jevon","year":"1999","unstructured":"Jevon M, Guo C, Ma B, Mordan N, Nair SP, Harris M, et al. Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblasts. Infect Immun. 1999;67:2677\u201381.","journal-title":"Infect Immun."},{"key":"4383_CR137","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1006\/mpat.1999.0272","volume":"26","author":"JK Ellington","year":"1999","unstructured":"Ellington JK, Reilly SS, Ramp WK, Smeltzer MS, Kellam JF, Hudson MC. Mechanisms of Staphylococcus aureus invasion of cultured osteoblasts. Microb Pathog. 1999;26:317\u201323.","journal-title":"Microb Pathog."},{"key":"4383_CR138","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tim.2008.11.005","volume":"17","author":"C Garzoni","year":"2009","unstructured":"Garzoni C, Kelley WL. Staphylococcus aureus : new evidence for intracellular persistence. Trends Microbiol. 2009;17:59\u201365.","journal-title":"Trends Microbiol."},{"issue":"3","key":"4383_CR139","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3892\/etm.2011.423","volume":"3","author":"S Shi","year":"2012","unstructured":"Shi S, Zhang X. Interaction of Staphylococcus aureus with osteoblasts (Review). Exp Ther Med. 2012;3(3):367\u201370. https:\/\/doi.org\/10.3892\/etm.2011.423.","journal-title":"Exp Ther Med."},{"issue":"10","key":"4383_CR140","doi-asserted-by":"publisher","first-page":"e00237","DOI":"10.1128\/IAI.00237-18","volume":"86","author":"K Perez","year":"2018","unstructured":"Perez K, Patel R. Survival of Staphylococcus epidermidis in Fibroblasts and Osteoblasts. Infect Immun. 2018;86(10):e00237\u201318. https:\/\/doi.org\/10.1128\/IAI.00237-18.","journal-title":"Infect Immun."},{"issue":"2","key":"4383_CR141","doi-asserted-by":"publisher","first-page":"e01990","DOI":"10.1128\/AAC.01990-16","volume":"61","author":"L Zhang","year":"2017","unstructured":"Zhang L, Sun L, Wei R, et al. Intracellular Staphylococcus aureus Control by Virulent Bacteriophages within MAC-T Bovine Mammary Epithelial Cells. Antimicrob Agents Chemother. 2017;61(2):e01990\u201316.","journal-title":"Antimicrob Agents Chemother."},{"issue":"3","key":"4383_CR142","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00430-006-0011-4","volume":"195","author":"A Przerwa","year":"2006","unstructured":"Przerwa A, Zimecki M, Swita\u0142a-Jele\u0144 K, et al. Effects of bacteriophages on free radical production and phagocytic functions. Med Microbiol Immunol. 2006;195(3):143\u201350. https:\/\/doi.org\/10.1007\/s00430-006-0011-4.","journal-title":"Med Microbiol Immunol."},{"key":"4383_CR143","doi-asserted-by":"publisher","unstructured":"Borysowski J, Wierzbicki P, K\u0142osowska D, Korczak-Kowalska G, Weber-D\u0105browska B, Gorski A. The effects of T4 and A3\/R phage preparations on whole-blood monocyte and neutrophil respiratory bursts. Viral Immunol. 2010:541\u20134. https:\/\/doi.org\/10.1089\/vim.2010.0001.","DOI":"10.1089\/vim.2010.0001"},{"key":"4383_CR144","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/B978-0-12-394438-2.00002-5","volume":"83","author":"A G\u00f3rski","year":"2012","unstructured":"G\u00f3rski A, Mi\u0119dzybrodzki R, Borysowski J, D\u0105browska K, Wierzbicki P, et al. Phage as a modulator of immune responses. Practical implications for phage therapy. Adv Virus Res. 2012;83:41\u201371. https:\/\/doi.org\/10.1016\/B978-0-12-394438-2.00002-5.","journal-title":"Adv Virus Res."},{"key":"4383_CR145","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2217\/fmb-2017-0049","volume":"12","author":"A G\u00f3rski","year":"2017","unstructured":"G\u00f3rski A, D\u0105browska K, Mi\u0119dzybrodzki R, et al. Phages and immunomodulation. Future Microbiol. 2017;12:905\u201314. https:\/\/doi.org\/10.2217\/fmb-2017-0049.","journal-title":"Future Microbiol."},{"issue":"2","key":"4383_CR146","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1128\/AAC.01426-15","volume":"60","author":"R Pabary","year":"2015","unstructured":"Pabary R, Singh C, Morales S, et al. Anti-pseudomonal bacteriophage reduces infective burden and inflammatory response in murine lung. Antimicrob Agents Chemother. 2015;60(2):744\u201351. https:\/\/doi.org\/10.1128\/AAC.01426-15.","journal-title":"Antimicrob Agents Chemother."},{"issue":"1","key":"4383_CR147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-08336-9","volume":"7","author":"JD Van Belleghem","year":"2017","unstructured":"Van Belleghem JD, Clement F, Merabishvili M, Lavigne R, Vaneechoutte M. Pro-and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages. Sci Rep. 2017;7(1):1\u201313.","journal-title":"Sci Rep."},{"issue":"1","key":"4383_CR148","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.transproceed.2005.12.073","volume":"38","author":"A Gorski","year":"2006","unstructured":"Gorski A, Kniotek M, Perkowska-Ptasi\u0144ska A, et al. Bacteriophages and transplantation tolerance. Transplant Proc. 2006;38(1):331\u20133. https:\/\/doi.org\/10.1016\/j.transproceed.2005.12.073.","journal-title":"Transplant Proc."},{"issue":"1","key":"4383_CR149","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbrc.2010.09.094","volume":"402","author":"S Hashiguchi","year":"2010","unstructured":"Hashiguchi S, Yamaguchi Y, Takeuchi O, Akira S, Sugimura K. Immunological basis of M13 phage vaccine: Regulation under MyD88 and TLR9 signalling. Biochem Biophys Res Commun. 2010;402(1):19\u201322. https:\/\/doi.org\/10.1016\/j.bbrc.2010.09.094.","journal-title":"Biochem Biophys Res Commun."},{"key":"4383_CR150","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3389\/fmicb.2018.01614","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang L, Hou X, Sun L, et al. Staphylococcus aureus bacteriophage suppresses LPS-Induced Inflammation in MAC-T bovine mammary epithelial cells [published correction appears in Front Microbiol. 2018 9;9:2511]. Front Microbiol. 2018;9:1614. https:\/\/doi.org\/10.3389\/fmicb.2018.01614.","journal-title":"Front Microbiol"},{"issue":"12","key":"4383_CR151","doi-asserted-by":"publisher","first-page":"e0226574","DOI":"10.1371\/journal.pone.0226574","volume":"14","author":"JL Morris","year":"2019","unstructured":"Morris JL, Letson HL, Elliott L, Grant AL, Wilkinson M, Hazratwala K, et al. Evaluation of bacteriophage as an adjunct therapy for treatment of peri-prosthetic joint infection caused by Staphylococcus aureus. PLoS One. 2019;14(12):e0226574. https:\/\/doi.org\/10.1371\/journal.pone.0226574.","journal-title":"PLoS One."},{"issue":"1","key":"4383_CR152","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0971-5916.178615","volume":"143","author":"C Kishor","year":"2016","unstructured":"Kishor C, Mishra RR, Saraf SK, Kumar M, Srivastav AK, Nath G. Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model. Indian J Med Res. 2016;143(1):87\u201394.","journal-title":"Indian J Med Res"},{"issue":"5","key":"4383_CR153","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/antibiotics9050241","volume":"9","author":"JB Doub","year":"2020","unstructured":"Doub JB, Ng VY, Johnson AJ, Slomka M, Fackler J, Horne B, et al. Salvage Bacteriophage Therapy for a Chronic MRSA Prosthetic Joint Infection. Antibiotics (Basel). 2020;9(5):241. https:\/\/doi.org\/10.3390\/antibiotics9050241.","journal-title":"Antibiotics (Basel)."},{"issue":"11","key":"4383_CR154","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/cid\/ciz222","volume":"69","author":"R Nir-Paz","year":"2019","unstructured":"Nir-Paz R, Gelman D, Khouri A, Sisson BM, Fackler J, Alkalay-Oren S, et al. Successful Treatment of Antibiotic-resistant, Poly-microbial Bone Infection with Bacteriophages and Antibiotics Combination. Clin Infect Dis. 2019;69(11):2015\u20138. https:\/\/doi.org\/10.1093\/cid\/ciz222.","journal-title":"Clin Infect Dis."},{"issue":"8","key":"4383_CR155","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00264-012-1546-1","volume":"36","author":"P Kodumuri","year":"2012","unstructured":"Kodumuri P, Geutjens G, Kerr HL. Time delay between diagnosis and arthroscopic lavage in septic arthritis. Does it matter? Int Orthop. 2012;36(8):1727\u201331. https:\/\/doi.org\/10.1007\/s00264-012-1546-1.","journal-title":"Int Orthop."},{"issue":"3S","key":"4383_CR156","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.arth.2019.10.062","volume":"35","author":"CM Davis","year":"2020","unstructured":"Davis CM, Zamora RA. Surgical Options and Approaches for Septic Arthritis of the Native Hip and Knee Joint. J Arthroplasty. 2020;35(3S):S14\u20138. https:\/\/doi.org\/10.1016\/j.arth.2019.10.062.","journal-title":"J Arthroplasty."},{"issue":"2","key":"4383_CR157","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1128\/AAC.00635-06","volume":"51","author":"R Watanabe","year":"2007","unstructured":"Watanabe R, Matsumoto T, Sano G, et al. Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother. 2007;51(2):446\u201352. https:\/\/doi.org\/10.1128\/AAC.00635-06.","journal-title":"Antimicrob Agents Chemother."},{"issue":"3","key":"4383_CR158","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1751-7915.2008.00028.x","volume":"1","author":"KP Kim","year":"2008","unstructured":"Kim KP, Cha JD, Jang EH, et al. PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response. Microb Biotechnol. 2008;1(3):247\u201357. https:\/\/doi.org\/10.1111\/j.1751-7915.2008.00028.x.","journal-title":"Microb Biotechnol."},{"key":"4383_CR159","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-394438-2.00001-3","volume":"83","author":"N Chanishvili","year":"2012","unstructured":"Chanishvili N. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches. Adv Virus Res. 2012;83:3\u201340. https:\/\/doi.org\/10.1016\/B978-0-12-394438-2.00001-3.","journal-title":"Adv Virus Res."},{"issue":"10","key":"4383_CR160","doi-asserted-by":"publisher","first-page":"e00954","DOI":"10.1128\/AAC.00954-17","volume":"61","author":"RT Schooley","year":"2017","unstructured":"Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii Infection. Antimicrob Agents Chemother. 2017;61(10):e00954\u201317. https:\/\/doi.org\/10.1128\/AAC.00954-17.","journal-title":"Antimicrob Agents Chemother."},{"key":"4383_CR161","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fmed.2020.00342","volume":"7","author":"T Ferry","year":"2020","unstructured":"Ferry T, Batailler C, Petitjean C, Chateau J, Fevre C, Forestier E, et al. The potential innovative use of bacteriophages within the DAC\u00ae hydrogel to treat patients with knee megaprosthesis infection requiring \"debridement antibiotics and implant retention\" and soft tissue coverage as salvage therapy. Front Med (Lausanne). 2020;7:342. https:\/\/doi.org\/10.3389\/fmed.2020.00342.","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"4383_CR162","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-4362.2002.01451.x","volume":"41","author":"K Markoishvili","year":"2002","unstructured":"Markoishvili K, Tsitlanadze G, Katsarava R, Morris JG Jr, Sulakvelidze A. A novel sustained-release matrix based on biodegradable poly (ester amide) s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. Int J Dermatol. 2002;41(7):453\u20138. https:\/\/doi.org\/10.1046\/j.1365-4362.2002.01451.x PMID: 12121566.","journal-title":"Int J Dermatol."},{"key":"4383_CR163","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1365-2230.2004.01600","volume":"30","author":"D Jikia","year":"2005","unstructured":"Jikia D, Chkhaidze N, Imedashvili E, Mgaloblishvili I, Tsitlanadze G, Katsarava R, et al. The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90. Clin Exp Dermatol. 2005;30:23\u20136. https:\/\/doi.org\/10.1111\/j.1365-2230.2004.01600.","journal-title":"Clin Exp Dermatol."},{"issue":"3","key":"4383_CR164","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/jpids\/pix056","volume":"7","author":"C Duplessis","year":"2018","unstructured":"Duplessis C, Biswas B, Hanisch B, Perkins M, Henry M, Quinones J, et al. Refractory Pseudomonas Bacteremia in a 2-Year-Old Sterilized by Bacteriophage Therapy. J Pediatric Infect Dis Soc. 2018;7(3):253\u20136. https:\/\/doi.org\/10.1093\/jpids\/pix056.","journal-title":"J Pediatric Infect Dis Soc."},{"issue":"1","key":"4383_CR165","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13054-017-1709-y","volume":"21","author":"S Jennes","year":"2017","unstructured":"Jennes S, Merabishvili M, Soentjens P, Pang KW, Rose T, Keersebilck E, et al. Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report. Crit Care. 2017;21(1):129. https:\/\/doi.org\/10.1186\/s13054-017-1709-y.","journal-title":"Crit Care."},{"issue":"6","key":"4383_CR166","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00167-011-1676-9","volume":"20","author":"VC Fotopoulos","year":"2012","unstructured":"Fotopoulos VC, Tzinia A, Tzurbakis M, Kalfakakou V, Levidiotou-Stefanou S, Georgoulis A. Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2012;20(6):1159\u201367. https:\/\/doi.org\/10.1007\/s00167-011-1676-9.","journal-title":"Knee Surg Sports Traumatol Arthrosc."},{"key":"4383_CR167","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.micpath.2016.08.021","volume":"99","author":"S Sultana","year":"2016","unstructured":"Sultana S, Adhikary R, Nandi A, Bishayi B. Neutralization of MMP-2 protects Staphylococcus aureus infection induced septic arthritis in mice and regulates the levels of cytokines. Microb Pathog. 2016;99:148\u201361. https:\/\/doi.org\/10.1016\/j.micpath.2016.08.021.","journal-title":"Microb Pathog."},{"key":"4383_CR168","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/ard.59.6.455","volume":"59","author":"Y Yoshihara","year":"2000","unstructured":"Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis. 2000;59:455.","journal-title":"Ann Rheum Dis."},{"key":"4383_CR169","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2741\/1817","volume":"11","author":"PS Burrage","year":"2006","unstructured":"Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006;11:529\u201343. https:\/\/doi.org\/10.2741\/1817 PMID: 16146751.","journal-title":"Front Biosci."},{"issue":"6","key":"4383_CR170","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.micinf.2006.01.001","volume":"8","author":"AM Calander","year":"2006","unstructured":"Calander AM, Starckx S, Opdenakker G, Bergin P, Quiding-J\u00e4rbrink M, Tarkowski A. Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis. Microbes Infect. 2006;8(6):1434\u20139. https:\/\/doi.org\/10.1016\/j.micinf.2006.01.001.","journal-title":"Microbes Infect."},{"issue":"4","key":"4383_CR171","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/art.33450","volume":"64","author":"M Puliti","year":"2012","unstructured":"Puliti M, Momi S, Falcinelli E, Gresele P, Bistoni F, Tissi L. Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. Arthritis Rheum. 2012;64(4):1089\u201397. https:\/\/doi.org\/10.1002\/art.33450.","journal-title":"Arthritis Rheum."},{"issue":"Pt 1","key":"4383_CR172","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1242\/jcs.114.1.131","volume":"114","author":"YP Han","year":"2001","unstructured":"Han YP, Tuan TL, Wu H, Hughes M, Garner WL. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa) B mediated induction of MT1-MMP. J Cell Sci. 2001;114(Pt 1):131\u20139.","journal-title":"J Cell Sci."},{"issue":"6","key":"4383_CR173","doi-asserted-by":"publisher","first-page":"R176","DOI":"10.1186\/ar2086","volume":"8","author":"S Kanangat","year":"2006","unstructured":"Kanangat S, Postlethwaite A, Hasty K, et al. Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther. 2006;8(6):R176. https:\/\/doi.org\/10.1186\/ar2086.","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"4383_CR174","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12026-017-8979-y","volume":"66","author":"S Sultana","year":"2018","unstructured":"Sultana S, Dey R, Bishayi B. Dual neutralization of TNFR-2 and MMP-2 regulates the severity of S. aureus induced septic arthritis correlating alteration in the level of interferon gamma and interleukin-10 in terms of TNFR2 blocking. Immunol Res. 2018;66(1):97\u2013119. https:\/\/doi.org\/10.1007\/s12026-017-8979-y.","journal-title":"Immunol Res."},{"issue":"2-3","key":"4383_CR175","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.micpath.2004.12.005","volume":"38","author":"I Gjertsson","year":"2005","unstructured":"Gjertsson I, Innocenti M, Matrisian LM, Tarkowski A. Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis. Microb Pathog. 2005;38(2-3):97\u2013105. https:\/\/doi.org\/10.1016\/j.micpath.2004.12.005.","journal-title":"Microb Pathog."},{"key":"4383_CR176","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.4049\/jimmunol.161.7.3340","volume":"161","author":"U Sch\u00f6nbeck","year":"1998","unstructured":"Sch\u00f6nbeck U, Mach F, Libby P. Generation of biologically active IL-1\u03b2 by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1\u03b2 processing. J Immunol. 1998;161:3340.","journal-title":"J Immunol."},{"key":"4383_CR177","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3389\/fimmu.2018.00962","volume":"9","author":"L Staurengo-Ferrari","year":"2018","unstructured":"Staurengo-Ferrari L, Trevelin SC, Fattori V, et al. Interleukin-33 Receptor (ST2) Deficiency Improves the Outcome of Staphylococcus aureus-Induced Septic Arthritis. Front Immunol. 2018;9:962. https:\/\/doi.org\/10.3389\/fimmu.2018.00962.","journal-title":"Front Immunol."},{"issue":"5","key":"4383_CR178","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/infdis\/jis295","volume":"206","author":"L Henningsson","year":"2012","unstructured":"Henningsson L, Jirholt P, Bogest\u00e5l YR, Eneljung T, Adiels M, Lindholm C, et al. Interleukin 15 mediates joint destruction in Staphylococcus aureus arthritis. J Infect Dis. 2012;206(5):687\u201396. https:\/\/doi.org\/10.1093\/infdis\/jis295.","journal-title":"J Infect Dis."},{"issue":"3","key":"4383_CR179","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1046\/j.1365-2249.2002.01999.x","volume":"130","author":"I Gjertsson","year":"2002","unstructured":"Gjertsson I, Hultgren OH, Tarkowski A. Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin Exp Immunol. 2002;130(3):409\u201314.","journal-title":"Clin Exp Immunol."},{"issue":"3","key":"4383_CR180","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/art.10170","volume":"46","author":"M Puliti","year":"2002","unstructured":"Puliti M, von Hunolstein C, Bistoni F, et al. The beneficial effect of interleukin-12 on arthritis induced by group B streptococci is mediated by interferon-\u03b3 and interleukin-10 production. Arthritis Rheum. 2002;46(3):806\u201317.","journal-title":"Arthritis Rheum."},{"issue":"10","key":"4383_CR181","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.4049\/jimmunol.160.10.5082","volume":"160","author":"O Hultgren","year":"1998","unstructured":"Hultgren O, Kopf M, Tarkowski A. Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth. J Immunol. 1998;160(10):5082\u20137. 9590259.","journal-title":"J Immunol."},{"issue":"6","key":"4383_CR182","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/jor.24584","volume":"38","author":"JM Gilbertie","year":"2020","unstructured":"Gilbertie JM, Schaer TP, Schubert AG, Jacob ME, Menegatti S, Ashton Lavoie R, et al. Platelet-rich plasma lysate displays anti-biofilm properties and restores antimicrobial activity against synovial fluid biofilms in vitro. J Orthop Res. 2020;38(6):1365\u201374. https:\/\/doi.org\/10.1002\/jor.24584.","journal-title":"J Orthop Res."},{"issue":"6","key":"4383_CR183","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.arth.2017.12.028","volume":"33","author":"YJ Cho","year":"2018","unstructured":"Cho YJ, Patel D, Chun YS, Shin WJ, Rhyu KH. Novel Antibiotic-Loaded Cement Femoral Head Spacer for the Treatment of Advanced Pyogenic Arthritis in Adult Hip. J Arthroplasty. 2018;33(6):1899\u2013903. https:\/\/doi.org\/10.1016\/j.arth.2017.12.028.","journal-title":"J Arthroplasty."},{"issue":"8","key":"4383_CR184","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/polym10080890","volume":"10","author":"YH Hsu","year":"2018","unstructured":"Hsu YH, Chen DW, Li MJ, Yu YH, Chou YC, Liu SJ. Sustained Delivery of Analgesic and Antimicrobial Agents to Knee Joint by Direct Injections of Electrosprayed Multipharmaceutical-Loaded Nano\/Microparticles. Polymers (Basel). 2018;10(8):890. https:\/\/doi.org\/10.3390\/polym10080890.","journal-title":"Polymers (Basel)."},{"issue":"12","key":"4383_CR185","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5312\/wjo.v10.i12.424","volume":"10","author":"BJ Schultz","year":"2019","unstructured":"Schultz BJ, Sweeney T, DeBaun MR, Remmel M, Midic U, Khatri P, et al. Pilot study of a novel serum mRNA gene panel for diagnosis of acute septic arthritis. World J Orthop. 2019;10(12):424\u201333. https:\/\/doi.org\/10.5312\/wjo.v10.i12.424.","journal-title":"World J Orthop."},{"issue":"8","key":"4383_CR186","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.ajem.2017.06.014","volume":"35","author":"J Zhao","year":"2017","unstructured":"Zhao J, Zhang S, Zhang L, Dong X, Li J, Wang Y, et al. Serum procalcitonin levels as a diagnostic marker for septic arthritis: A meta-analysis. Am J Emerg Med. 2017;35(8):1166\u201371. https:\/\/doi.org\/10.1016\/j.ajem.2017.06.014.","journal-title":"Am J Emerg Med."},{"key":"4383_CR187","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1749-799X-8-19","volume":"8","author":"K Maharajan","year":"2013","unstructured":"Maharajan K, Patro DK, Menon J, Hariharan AP, Parija SC, Poduval M, et al. Serum Pro-calcitonin is a sensitive and specific marker in the diagnosis of septic arthritis and acute osteomyelitis. J Orthop Surg Res. 2013;8:19. https:\/\/doi.org\/10.1186\/1749-799X-8-19.","journal-title":"J Orthop Surg Res."},{"key":"4383_CR188","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.imlet.2020.02.001","volume":"220","author":"S Sultana","year":"2020","unstructured":"Sultana S, Bishayi B. Etoposide-mediated depletion of peripheral blood monocytes post S. aureus infection attenuates septic arthritis by modulating macrophage-derived factors responsible for inflammatory destruction. Immunol Lett. 2020;220:51\u201362. https:\/\/doi.org\/10.1016\/j.imlet.2020.02.001.","journal-title":"Immunol Lett."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04383-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04383-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04383-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T19:05:15Z","timestamp":1675451115000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04383-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":188,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["4383"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04383-6","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"530"}}